Operators Are the Main Source of Contamination in Pharmaceutical Manufacturing
In this short clip from the June episode of our Ask the Expert video series, Simona Guidi, Associate Director, Cell and Gene Therapies at ProPharma, explains the importance of considering humans as a top source of contamination in pharmaceutical manufacturing.
Check out the full episode with Guidi on Adventitious Contamination Control in which she answers questions about options for controlling adventitious contamination for cell processing requiring extensive manipulation and how to protect the product and operating when moving to a closed processing system for cell therapy production.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
